Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEBRA: AZD2014 vs Everolimus in Metastatic Renal Cancer
NCT01793636Phase 2Terminated
- Sponsor
- Queen Mary University of London
- Start
- Feb 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vistusertib in renal cell carcinoma (RCC), sponsored by Queen Mary University of London. Started Feb 2013; status: terminated.
02
Drugs
vistusertib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01793636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01793636.